Macroaxis: Personalized Investing
Simple Personalized Investing

FNMFO FNMFO 096770 KDDIF Hotels Utilities Health Management 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for QRXPY

QRxPharma quote and profile

 
 Companies |  Insiders  | Dashboard  
     
5.85
  
OTC STOCK
0.00  No Change   0.00%  
Last 1 Month(s)
5.856.15
May 24 2013 

Diversification Suggestion

Use QRxPharma to protect against small markets fluctuations. The stock experiences no pattern. Wait for more market signals and watch out for any hype
Analyze QRxPharma Pty Trend or Check current 30 days QRxPharma correlation with market (S&P 500)
1 Month Beta -0.07  
Highest Price:  
Lowest Price:  
6.15  
5.85  
May 16 2013 
May 23 2013 
As returns on market increase, returns on owning QRxPharma are expected to decrease at a much smaller rate. During bear market, QRxPharma is likely to outperform the market.
QRxPharma Pty Ltd Almost negative betaQRxPharma Pty Beta Legend
QRXPY United States OTC
QRxPharma Pty Ltd
Benchmark S&P 500
http://www.qrxpharma.com
Contact Number: 61 2 9492 8021
Traded on OTC Market
    
Current Valuation225.31 M
Shares Outstanding28.86 M
Revenue422.74 K
Cash and Equivalents32.37 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.00 % No Change  
 thisGreen QRXPY QRXPY.PK agains markets  0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

QRxPharma Leadership

John Holaday CEO, Managing Director, Executive Director, Ph.D
Peter Farrell Non-Executive Chairman of the Board
Philip Magistro Vice President - Commercial Operations
Richard Paul Executive Vice President Drug Development

QRxPharma Price and Market Media

The median price of QRxPharma for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 6.0 with a coefficient of variation of 1.79. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 5.99, and mean deviation of 0.08. The Stock did not receive any noticable media coverage during the period.
QRxPharma         SP 500
Price Growth (%)
 

QRxPharma Summary

QRxPharma Pty Ltd [QRXPY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with current market capitalization of 257.68 M. QRxPharma Pty Ltd has 28.86 M outstanding shares.
QRxPharma Limited, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for pain management and central nervous system disorders. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
43 %
 
Follow QRxPharma with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add QRxPharma to your reader
 

QRxPharma Research Report

QRxPharma vs. Federal

Correlation analysis and fundamentals comparison between QRxPharma Pty and Federal National Mor

QRxPharma Executives

Chris Campbell CFO, Company Secretary
Edward Rudnic COO

QRxPharma Directors

R Campbell Non-Executive Director
Gary Pace Non-Executive Director, Ph.D
Michael Quinn Non - Executive Director, MBA

QRxPharma Management

Patricia Richards Chief Medical Officer

QRxPharma Fundamentals

Cash Flow from Operations vs Market Capitalization
Current Valuation vs Revenue
Cash Flow from Operations vs EBITDA
One Year High vs Revenue

QRxPharma vs Competition

QRxPharma vs. Federal National Mortgage Association
QRxPharma vs. Federal National Mortgage Association
QRxPharma vs. SK Innovation
QRxPharma vs. KDDI Corp
QRxPharma vs. Japan Tobacco Inc
QRxPharma vs. Inpex Corporation
QRxPharma vs. AP M
QRxPharma vs. AP M
QRxPharma vs. Citigroup Inc
QRxPharma vs. Akbank TAS

QRxPharma May 24 2013 Opportunity Range

Downside Deviation2.35
Information Ratio(0.08)
Maximum Drawdown6.9
Value At Risk(2.50)
Potential Upside4.95

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium